Skip to main content
OpenTrials
Completed

NCT Number: NCT06204081

Short-Term Effect Of Ceriter Stride One (CSO) on FOG and Falling in pwP

The Ceriter Stride One (CSO) is a "smart sole" with pressure sensors. The sole allows data on the displacement of the body's centre of gravity (COG), as well as spatiotemporal parameters, to be obtained via pressure recordings. Logarithms, released on the data captured by the sole, make it possible to recognise propulsion (forward movement of the CG), accompanied by a reduction in step length (festination) or feet remaining standing (freezing of gait). When the system registers incipient propulsion, an audio signal ("stop") is generated via an audio device and app on the mobile phone. The CSO aims to make the pwP stop before balance disturbance can occur, preventing further propulsion and falls.

The aim of the study is to explore the short-term effects of the CSO in terms of reducing (preventing) freezing of gait and fall risk in a pilot group of pwP whose functionality is limited (Hoehn and Yahr 4). Short-term impact on gait (episodes of freezing of gait, mean step length, mean gait speed) will be evaluated and user satisfaction surveyed.

Completed

Looking for future studies?

Notify Me

Key information

About this study

There is scientific evidence for making pwP stop at the onset of propulsion (when step length decreases and step frequency increases) in order to get the COG back within the base of support. Similarly, (auditory) cues are recommended to facilitate starting.

These principles are implemented with the CSO : the device makes the pmP stop at onset of propulsion and generates an auditory, rhythmic cue to facilitate starting and walking with larger steps (prevention).

This is an innovative application, not a standard-of-care intervention.

Protocol :

20 persons with Parkinson's disease (H&Y 4) (attending physical therapy at Movita).

The test proceeds in 3 stages : preparation / gait test / subjective evaluation :

Preparation

  • Info / IC
  • General data : age, sex, number of years since diagnosis, use of aids, medication, fall incidents last week (fall diary based on fall diary), (last intake) medication and current efficacy (VAS).
  • MDS-UPDRS-II (degree of dependence), nFOGQ, Montreal Cognitive Assessment (MOCA).

Clinical gait test :

The soles are placed in the patient's shoes. If the patient uses an assistive device in daily life, the test is performed with an assistive device.

Following procedure is done in a randomized order*:

  • Walking without auditory cue: for 3 minutes, the patient is asked to walk back and forth at a comfortable pace on a 4-meter course through a doorway (start : 2 meters before the doorway, stop : 2 meters beyond the doorway) without any auditory support. If no freezing occurs during this period, pwP is asked to turn 360° in the doorway.

The first 1.5 minutes gait is performed without a double task, the next 1.5 minutes with a cognitive double task (100 - 3 = ... - 3 = ... -3 = ...).

  • Walking with auditory cues: for 3 minutes the patient is asked to walk back and forth at a comfortable pace along a 4-meter course through a doorway (start : 2 meters in front of the doorway, stop : 2 meters beyond the doorway) with auditory cues given at the occurrence of a freeze. If no FOG occured, the pwP is asked to turn 360° in the doorway.

The first 1.5 minutes gait is performed without a dual task, the next 1.5 minutes with a cognitive dual task (100 - 3 = ... - 3 = ... -3 = ...).

After each condition (with - without auditory cueing) a short break (2 minutes) is taken, during which a Borg scale for fatigue is taken. After the second condition, satisfaction with the effect of the aid is questioned (see below).

The entire gait test is filmed (by a 2nd person). In this way data, including the number of freezing episodes, can be checked.

*Randomization of conditions: per 2 patients. The first patient draws a card indicating whether or not the patient starts with auditory cues while walking. The 2nd patient then starts with the other condition, and so on. Thus we obtain 10 patients starting with the auditory cueing condition and 10 without.

Parameters considered : duration/step, gait asymmetry (pressure of left foot vs. right foot), number of freezing periods, distance walked, number of steps, mean step length.

Satisfaction questions

  • On a scale of 1 to 10, how would you rate the level of comfort of the Ceriter Stride One?
  • On a scale of 1 to 10, how safe do you feel when using the Ceriter Stride One?
  • To what extent do you feel more secure, on a scale of 1 to 10, while walking by using the Ceriter Stride One?
  • Open question : do you have any comments, concerns or questions of your own?

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Parkinson's disease (or other Parkinsonism)

  • gait impairment with freezing of gait (FOG)
  • 18-80 years old
  • I.C. (informed consent)
  • Montreal Cognitive Assessment (MoCA) >25

Exclusion criteria

  • unable to walk 4m without assistance
  • MoCA < 25
  • no FOG

Treatment and study plan

CSO_without cueing

Device

The sole is worn without using the cueing application

CSO_cueing

Device

The sole is worn with using the cueing application

Primary outcomes

  1. The number of captured episodes with freezing of gait (FOG)

    Time frame: 2 times 3 minutes

    n (number of captured FOG-episodes : the less, the better)

  2. The number of captured steps

    Time frame: 2 times 3 minutes

    n (number - more steps relate to a better mobility)

  3. The difference between the pressure of steps with left versus right foot; as a measure of gait asymmetry.

    Time frame: 2 times 3 minutes

    mean presure data of left foot versus mean pressure data of right foot

  4. mean step length

    Time frame: 2 times 3 minutes

    mean step length (cm)

Secondary outcomes

  1. users satisfaction

    Time frame: after testing (5 min)

    comfort and safety of the tool are questioned on a scale of 1 to 10.

Sponsors and collaborators

Lead sponsor

University Ghent

Other

Registry information

Official study title

Exploration of the Short-term Effects and User Satisfaction of the Ceriter Stride One (CSO) Regarding the Prevention and Treatment of Freezing or Gait in Persons With Parkinson's Disease (pwP).

Acronym: CSO_FOG

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jan 12, 2024
Registry last updated
Jun 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.